Forecast
R&D Trends for 2013: Data Trims, Partnerships, and Emerging Global Players
The Tufts Center for the Study of Drug Development sees two key trends as increasingly important for pharmaceutical companies to maintain R&D success going forward. Additionally, there is the emergence of foreign players in key markets determined to steal a page from Big Pharma’s playbook ...Read more
Reputation
Pharma Still Doesn’t ‘Get’ Patient Groups
Despite a year of high drug approvals, patient groups’ lagging perceptions of progress in meeting medical need suggest that Big Pharma is still struggling to understand what “patient-centeredness” truly means, according to a survey of 600 patient groups worldwide conducted in late 2012 ...Read More
Sales and Marketing
Oncologists — in Detail
On average, cancer docs in the US would much rather deal with pharma sales reps in person as opposed to online, and drug companies are hiring more reps to support a slew of newly approved oncologic drugs, even as reps in other therapeutic areas get pink slips. But external pressures are likely to further limit a sales rep’s access to these physicians, according to a new report ...Read more
eHealth
Crowd Sourcing: The Time Has Come
It’s not new, not even for pharma. But crowd sourcing (use of web-based technologies to recruit project participants) is emerging as a hot, growing area with individuals using health social networks, crowd-sourced studies, smartphone health applications, and personal health records to achieve positive outcomes for a variety of health conditions ...Read more |
